International Journal of Medicine and Data

The strategy of individualized antihypertensive drug therapy is an important research direction based on pharmacogenomics. By analyzing patients genetic variations, pharmacogenomics can provide more precise drug choices for hypertensive patients, avoid drug side effects, and improve treatment efficacy. With the rising prevalence of hypertension, the traditional "one-size-fits-all" treatment approach can no longer meet patients personalized needs. Developing treatment plans based on genomic data has become a crucial way to enhance treatment efficiency and patient compliance. This study aims to explore how to apply pharmacogenomic principles to optimize individualized antihypertensive treatment regimens, analyze the relationship between genes and drug responses, and propose design ideas and implementation strategies for personalized treatment plans. The application of genomics can effectively guide drug selection, reduce side effects, enhance therapeutic effects, and provide a new direction for hypertension treatment.

Pharmacogenomics; Hypertension; Individualized treatment; Drug response; Genetic variation